Previous 10 | Next 10 |
2023-03-27 13:06:40 ET Gainers: WiSA Technologies ( WISA ) +93% . First Citizens BancShares ( FCNCA ) +50% . Alimera Sciences ( ALIM ) +38% . Cimpress ( CMPR ) +30% . Gorilla Technology Group ( GRRR ) +25% . CBL International...
2023-03-27 08:52:49 ET Unity Biotechnology UBX -47% after mid-stage setback for wet AMD candidate . NuCana ( NCNA ) -28% after the European Patent Office issues oral ruling that NuCana's '190 patent is not valid . Pharming Group PHAR -13% erasing today'...
2023-03-27 05:45:26 ET The shares of Dutch biotech Pharming Group N.V. ( NASDAQ: PHAR ) added ~24% on Monday in the Amsterdam stock exchange on the announcement of U.S. approval for the rare immune disorder therapy Joenja co-developed with Novartis ( NVS ). The FDA...
2023-03-24 15:00:32 ET Welcome to Seeking Alpha's Catalyst Watch - a breakdown of some of next week's actionable events that stand out. Check out Saturday morning's regular Stocks to Watch article for a full list of events planned for the week or the Seeking Alpha earnings calenda...
Pharming announces US FDA approval of Joenja® (leniolisib) as the first and only treatment indicated for APDS Canada NewsWire APDS (activated phosphoinositide 3-kinase delta (PI3Kδ) syndrome) is a rare and progressive primary immunodeficiency Joenja® is a ta...
2023-03-16 10:04:06 ET Pharming Group N.V. (PHGUF) Q4 2022 Earnings Call Transcript March 16, 2023 08:30 AM ET Company Participants Sijmen de Vries - Executive Director & Chief Executive Officer Anurag Relan - Chief Medical Officer Jeroen Wakkerman - Chief Fi...
2023-03-16 08:53:37 ET The following slide deck was published by Pharming Group N.V. in conjunction with their 2022 Q4 earnings call. For further details see: Pharming Group N.V. 2022 Q4 - Results - Earnings Call Presentation
Pharming announces first patient enrolled in pediatric clinical trial of leniolisib Canada NewsWire The multinational Phase III study is evaluating leniolisib tablets in children aged 4 to 11 years with APDS, a rare primary immunodeficiency LEIDEN, Netherlands ...
A panel of the European Medicines Agency (EMA) converted the review of Pharming's ( NASDAQ: PHAR ) drug leniolisib to standard review from accelerated assessment as the committee sent questions to the company, including requesting more data. The company's marketing authoriza...
Pharming provides update on EMA regulatory review of leniolisib for APDS in Europe Canada NewsWire EMA Marketing Authorisation Application for leniolisib changed to standard review timetable LEIDEN, Netherlands , Feb. 16, 2023 /CNW/ -- Pharming Group N.V. ("P...
News, Short Squeeze, Breakout and More Instantly...
2024-05-26 13:06:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
Apartment Investment and Management Company (AIV) is expected to report for Q1 2024 Shopify Inc. Class A Subordinate (SHOP) is expected to report $0.08 for Q1 2024 Beyond Meat Inc. (BYND) is expected to report $-0.68 for Q1 2024 Instructure Holdings Inc. (INST) is expected to report $...
AIA Group Limited ADR (AAGIY) is expected to report for Q4 2023 Bank of Georgia Group Plc (BDGSF) is expected to report for quarter end 2023-12-31 SecureWorks Corp. (SCWX) is expected to report $-0.15 for Q4 2024 Acacia Research Corporation (ACTG) is expected to report for quarter end...